Clinicopathologic comparison of familial versus sporadic atypical teratoid/rhabdoid tumors (AT/RT) of the central nervous system
- 16 September 2010
- journal article
- research article
- Published by Wiley in Pediatric Blood & Cancer
- Vol. 56 (7) , 1026-1031
Abstract
Background: Central nervous system (CNS) atypical teratoid/rhabdoid tumors (AT/RT) are aggressive tumors usually diagnosed in young children and characterized by SMARCB1 (INI1, hSNF5) gene abnormalities. Despite initial chemo‐radiation responsiveness, most children die of progressive disease (PD). Little data regarding familial AT/RT clinical course exist. This study described and compared familial (F) versus sporadic (S) AT/RT and elucidated SMARCB1 mutations and inheritance patterns.Methods: A retrospective chart review, pedigree, and SMARCB1 analysis were done.Results: Between January 1989 and June 2009, 20 children with CNS AT/RT were diagnosed, 8‐S and 12‐F. Median age at diagnosis (months) of S and F patient were: 13 and 4.8, respectively. Median survival (months) was S‐21, F4.5, and 8‐all. Pedigree analyses showed unaffected parent carriers with multiple affected offspring.Conclusions: Children with F‐AT/RT are younger, have more extensive disease, and are more likely to die from PD than children with S‐AT/RT. Surgery, radiation, and chemotherapy were important in achieving long‐term survival. Pedigree analysis supports autosomal dominant inheritance pattern with incomplete penetrance. Germline SMARCB1 mutation analysis is important in all patients diagnosed with AT/RT to (1) determine actual incidence of F‐AT/RT, (2) determine penetrance of predisposing mutations, (3) provide appropriate genetic counseling, and (4) establish surveillance screening guidelines. Pediatr Blood Cancer 2011;56:1026–1031.Keywords
This publication has 34 references indexed in Scilit:
- Genomic Analysis Using High-Density Single Nucleotide Polymorphism-Based Oligonucleotide Arrays and Multiplex Ligation-Dependent Probe Amplification Provides a Comprehensive Analysis of INI1/SMARCB1 in Malignant Rhabdoid TumorsClinical Cancer Research, 2009
- Familial occurrence of schwannomas and malignant rhabdoid tumour associated with a duplication in SMARCB1Journal of Medical Genetics, 2009
- Intensive induction chemotherapy followed by high dose chemotherapy with autologous hematopoietic progenitor cell rescue in young children newly diagnosed with central nervous system atypical teratoid rhabdoid tumorsPediatric Blood & Cancer, 2008
- Long-term survival and transmission of INI1-mutation via nonpenetrant males in a family with rhabdoid tumour predisposition syndromeBritish Journal of Cancer, 2007
- Predisposition to atypical teratoid/rhabdoid tumor due to an inherited INI1 mutationPediatric Blood & Cancer, 2005
- Treatment of CNS malignant rhabdoid tumorsPediatric Blood & Cancer, 2003
- Cerebral Atypical Teratoid/Rhabdoid Tumor of Infancy: Long-Term Survival after Multimodal Treatment, also Including Triple Intrathecal Chemotherapy and Gamma Knife Radiosurgery--Case ReportPediatric Hematology and Oncology, 2003
- Successful Treatment of Disseminated Central Nervous System Malignant Rhabdoid TumorJournal of Pediatric Hematology/Oncology, 1995
- Central nervous system atypical teratoid/rhabdoid tumors of infancy and childhoodJournal of Neuro-Oncology, 1995
- Monosomy 22 in Rhabdoid or Atypical Teratoid Tumors of the BrainNew England Journal of Medicine, 1989